NCT06009133

Brief Summary

Acute external thrombosed hemorrhoidal disease (AETHH) is one of the emergent complications of hemorrhoidal disease that results in pain and loss of work force. Although surgical excision is recommended in the treatment of AETHH in the guidelines of the American Society of Colorectal Surgeons (ASCRS) and the European Society of Coloproctology (ESCP), the level of evidence is low and it is emphasized that additional studies are needed. Therefore, the investigators aimed to compare the efficacy of surgical excision with medical treatment in the treatment of AETHH.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 17, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 24, 2023

Completed
Last Updated

August 28, 2023

Status Verified

August 1, 2023

Enrollment Period

6 months

First QC Date

August 17, 2023

Last Update Submit

August 24, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain score with visual analog scale

    The participants pain at the 12th hour postoperatively was scored with a visual analog scale. The visual analog scale was between 0 and 10 mm. 0 rated as no pain, 10 as very severe pain.

    12 hours

Secondary Outcomes (3)

  • Time to return to daily activities

    15 days

  • Recurrence

    6 months

  • Satisfaction survey

    6 months

Study Arms (2)

Conservative Treatment Group

Micronized purified flavonoid fraction, which is routinely used within indications in hemorrhoidal disease and recommended in ESCP and ASCRS guidelines, and licensed for use in hemorrhoidal disease by the Ministry of Health in our country, was given 2 g/day for one month. Also, Conservative methods (fiber foods, warm shower, regulation of toilet habits, laxatives and nonsteroidal anti-inflammatory drugs) were recommended.

Procedure: Conservative treatment

Surgical Treatment Group

While the patient was in the Jack-knife position, both hips were pulled laterally with tapes, appropriate visualization was obtained, the external thrombosed pack was excised under local anesthesia, and the wound was left to heal with secondary intention.Conservative methods were recommended in the surgical group as well as in the medical group.

Procedure: Surgical Treatment

Interventions

Micronized purified flavonoid fraction, which is routinely used within indications in hemorrhoidal disease and recommended in ESCP and ASCRS guidelines, and licensed for use in hemorrhoidal disease by the Ministry of Health in our country, was given 2 g/day for one month. Also, Conservative methods (fiber foods, warm shower, regulation of toilet habits, laxatives and nonsteroidal anti-inflammatory drugs) were recommended.

Conservative Treatment Group

While the patient was in the Jack-knife position, both hips were pulled laterally with tapes, appropriate visualization was obtained, the external thrombosed pack was excised under local anesthesia, and the wound was left to heal with secondary intention.Conservative methods were recommended in the surgical group as well as in the medical group.

Surgical Treatment Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The population of the study consisted of patients who applied to the general surgery outpatient clinic due to acute external thrombosed hemorrhoids disease. Patients who fully met the inclusion criteria and did not meet the exclusion criteria constituted the sample group.

You may qualify if:

  • Patients between the ages of 18-70 who present with isolated external thrombosed hemorrhoids
  • Patients with the onset of the complaint before 96 hours

You may not qualify if:

  • Patients under the age of 18 and patients over the age of 70
  • Mentally retarded patients
  • Pregnant patients
  • Patients with concomitant proctological disorders (anal fissure, anal fistula, anal abscess, etc.)
  • Those with a history of proctology surgery
  • Patients with grade 3-4 internal hemorrhoids
  • Patients using anticoagulant drugs
  • Patients whose complaint has passed 96 hours after onset

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Konya Training and Research Hospital

Konya, 42090, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Conservative TreatmentSurgical Procedures, Operative

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Hasan Yaldız, MD

    Konya City Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

August 17, 2023

First Posted

August 24, 2023

Study Start

July 1, 2022

Primary Completion

December 31, 2022

Study Completion

March 14, 2023

Last Updated

August 28, 2023

Record last verified: 2023-08

Locations